Measurements of plasma CNP products, including bioactive CNP and NTproCNP, have the potential to clarify organ responses to stress, injury, nutrients, hormone therapy, and exercise in adults.
Circulating CNP and NTproCNP may serve as useful biomarkers for assessing tissue-level responses to stress, injury, and extraneous factors in adults.
Paracrine actions of CNP and rapid degradation at source severely limit study of CNP's many roles in vivo. However provided sensitive and validated assays are used, there is increasing evidence that low concentrations of bioactive CNP in plasma, and the readily detectable concentrations of the bio-inactive processed product of proCNP (aminoterminal proCNP), can be used to advance understanding of the hormone's role in pathophysiology. Provided renal function is normal, concordant changes in both CNP and NTproCNP reflect change in tissue production of proCNP whereas change in CNP alone results from altered rates of bioactive CNP degradation and are reflected in the ratio of NTproCNP to CNP. As already shown in juveniles, where plasma concentration of CNP products are higher and are associated with concurrent endochondral bone growth, measurements of plasma CNP products in mature adults have potential to clarify organ response to stress and injury. Excepting the role of CNP in fetal-maternal welfare, this review examines evidence linking plasma CNP products with function of a wide range of tissues in adults, including the impact of extraneous factors such as nutrients, hormone therapy and exercise.
Prickett et al. (Sat,) conducted a review in Organ function in health and disease. Plasma CNP products (CNP and NTproCNP) was evaluated. Measurements of plasma CNP products, including bioactive CNP and NTproCNP, have the potential to clarify organ responses to stress, injury, nutrients, hormone therapy, and exercise in adults.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: